Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: Allelotyping and quantitative real-time PCR

International Journal of Cancer

Volumn 100, Issue 5, 2002, Pages 534-541

  Braga, Eleonora ^a,b   Senchenko, Vera ^b,c   Bazov, Igor ^a   Loginov, Witaly ^a   Liu, Jian ^b   Ermilova, Valeria ^d   Kazubskaya, Tatiana ^d   Garkavtseva, Raisa ^d   Mazurenko, Natalia ^d   Kisseljov, Fedor ^d   Lerman, Michael I ^e   Klein, George ^b   Kisselev, Lev ^f   Zabarovsky, Eugene R ^b,f,g  

^a Russian State Genetics Center   (Russian Federation)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF BIOENGINEERING   (Russian Federation)

^d N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^e NATIONAL CANCER INSTITUTE   (United States)

^f ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allelotyping; Chromosome 3p; Loss of heterozygosity; Renal cell carcinoma; Tumor suppressor gene

Indexed keywords

ALLELE; ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CENTROMERE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 3P; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE DELETION; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TELOMERE; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA;

BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, RENAL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PHYSICAL CHROMOSOME MAPPING; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 0037055570     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10511     Document Type: Article

References (52)

1. Proliferation, cell cycle and apoptosis in cancer
2. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes
3. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes
4. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
5. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3
6. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12
7. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation
8. HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA
9. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
10. Loss of expression of the DRR-1 gene at chromosomal segment 3p21.1 in renal cell carcinoma
11. RASSFIA inactivation in lung and breast cancer
12. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
13. Comparative allelotyping of the short arm of human chromosome 3 in epithelial tumors of four different types
14. Characterization of an 800 kb region at 3p22-p21.3 that was homozygously deleted in a lung cancer cell line
15. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin
16. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity
17. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: Progress toward the isolation of a lung cancer TSG
18. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
19. Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: A strategy for cloning the putative tumor suppressor gene
20. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma
21. Detection of specific polymerase chain product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase
22. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
23. Real time quantitative PCR
24. Human chromosome 3: Detection of microsatellites of di-, tri- and tetra-motifs, analysis of its allocation and markers formation
25. Analysis of NotI linking clones isolated from human chromosome 3 specific libraries
26. Gene dosage quantitative real-time PCR
27. Detailed microsatellite analysis of chromosome 3p region in non-papillary renal cell carcinomas
28. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas
29. Loss of heterozygosity in tumor cells requires reevaluation: The data are biased by the size-dependent differential sensitivity of allele detection
30. A group of NotI jumping and linking clones cover 2.5 Mb in the 3p21-p22 region suspected to contain a tumor suppressor gene
31. High-resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints
32. Role of FHIT in human cancer
33. Involvement of multiple loci on chromosome 3 in renal cell cancer development
34. Deletion of the short arm of chromosome 3 in breast tumors
35. Detailed deletion mapping of chromosome arm 3p in breast cancers: A 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors
36. High resolution analysis of chromosome 3p alterations in cervical carcinoma
37. Deletion of chromosome 3p is an early event in malignant progression of cervical cancer
38. Comparison of chromosome 3p deletions between cervical precancers synchronous with and without invasive cancer
39. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumorigenesis
40. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development
41. Molecular damage in the bronchial epithelium of current and former smokers
42. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
43. Mechanisms underlying losses of heterozygosity in human colorectal cancers
44. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer
45. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines
46. Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma
47. Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice
48. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice
49. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis
50. Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence of polyclonal origin of cervical squamous carcinoma
51. Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors